Corline Biomedical AB (CLBIO) — Cash Flow Quality Index
Corline Biomedical AB (CLBIO) has a Cash Flow Quality Index of -7.82x as of September 2023. Operating cash flow of Skr-1.60 Million is below net income of Skr204.00K, suggesting accrual-heavy earnings not yet converted to cash. Also explore CLBIO total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Corline Biomedical AB Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for Corline Biomedical AB across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CLBIO tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Corline Biomedical AB (2022–2022)
Year-by-year earnings quality comparison for Corline Biomedical AB. For live market cap and the full company financial profile, see how much is Corline Biomedical AB worth.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -2.77x | Skr-6.45 Million | Skr2.33 Million | — |